Skip to main content
Erschienen in: Pediatric Nephrology 2/2005

01.02.2005 | Original Article

Renal tubular dysfunction in children with systemic lupus erythematosus

verfasst von: Stephen D. Marks, Vanita Shah, Clarissa Pilkington, Patricia Woo, Michael J. Dillon

Erschienen in: Pediatric Nephrology | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Renal tubular and glomerular function was studied in patients under 18 years of age with childhood-onset systemic lupus erythematosus (SLE) in relation to disease activity in two groups: patients with clinical or laboratory evidence of lupus nephritis and those without (lupus non-nephritis). We reviewed 11 patients with lupus non-nephritis and 10 patients with lupus nephritis over a 12-month period. The measured glomerular filtration rates had a tendency to be lower in the lupus nephritis group. Glomerular dysfunction was manifest in the lupus nephritis group with elevated urinary albumin/creatinine ratios (P <0.001). Markers of tubular function were measured and compared with data from 94 controls. The lupus nephritis group had elevated urinary NAG [ N -acetyl-β- d -glucosaminidase (P =0.001)] and RBP [retinol-binding protein (P =0.03)] levels. Tubular dysfunction with elevated urinary NAG levels was present in 2 lupus non-nephritis patients with no evidence of glomerular disease. The cohort of patients in this study was followed and 2 lupus non-nephritis patients with the highest urinary RBP levels developed evidence of glomerular dysfunction and biopsy-proven lupus nephritis. Evidence of tubular dysfunction in lupus non-nephritis patients may help to identify lupus nephritis prior to the onset of albuminuria.
Literatur
1.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
2.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 9:1725 Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 9:1725
3.
Zurück zum Zitat Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635–2642PubMed Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635–2642PubMed
4.
Zurück zum Zitat Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34:866–872PubMed Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34:866–872PubMed
5.
Zurück zum Zitat Kaufman DB, Laxer RM, Silverman ED, Stein L (1986) Systemic lupus erythematosus in childhood and adolescence—the problem, epidemiology, incidence, susceptibility, genetics and prognosis. Curr Probl Pediatr 16:555–624 Kaufman DB, Laxer RM, Silverman ED, Stein L (1986) Systemic lupus erythematosus in childhood and adolescence—the problem, epidemiology, incidence, susceptibility, genetics and prognosis. Curr Probl Pediatr 16:555–624
6.
Zurück zum Zitat Lacks S, White P (1990) Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 17:941–945PubMed Lacks S, White P (1990) Morbidity associated with childhood systemic lupus erythematosus. J Rheumatol 17:941–945PubMed
7.
Zurück zum Zitat Jacobs JC (1977) Treatment of systemic lupus erythematosus in childhood. Arthritis Rheum 20:304−307PubMed Jacobs JC (1977) Treatment of systemic lupus erythematosus in childhood. Arthritis Rheum 20:304−307PubMed
8.
Zurück zum Zitat Churg J, Sobin LH (1982) Glomerulonephritis of systemic disease: lupus nephritis. In: Churg J, Sobin LH (eds) Renal disease. Classification and atlas of glomerular disease. Igaku-Shoin, Tokyo, pp 127–149 Churg J, Sobin LH (1982) Glomerulonephritis of systemic disease: lupus nephritis. In: Churg J, Sobin LH (eds) Renal disease. Classification and atlas of glomerular disease. Igaku-Shoin, Tokyo, pp 127–149
9.
Zurück zum Zitat Malleson PN (1989) The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol 7:563–566PubMed Malleson PN (1989) The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol 7:563–566PubMed
10.
Zurück zum Zitat Esdaile JM, Joseph L, Mackenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21:2046–2051PubMed Esdaile JM, Joseph L, Mackenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21:2046–2051PubMed
11.
Zurück zum Zitat Meislin AG, Rothfield N (1968) Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42:37–49PubMed Meislin AG, Rothfield N (1968) Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42:37–49PubMed
12.
Zurück zum Zitat Comerford FR, Cohen AS (1967) The nephropathy of systemic lupus erythematosus: an assessment by clinical, light and electron microscopic criteria. Medicine (Baltimore) 46:425 Comerford FR, Cohen AS (1967) The nephropathy of systemic lupus erythematosus: an assessment by clinical, light and electron microscopic criteria. Medicine (Baltimore) 46:425
13.
Zurück zum Zitat Woolf A, Croker B, Osofsky SG, Kredich DW (1979) Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment. Pediatrics 64:678–685PubMed Woolf A, Croker B, Osofsky SG, Kredich DW (1979) Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment. Pediatrics 64:678–685PubMed
14.
Zurück zum Zitat Weis LS, Pachman LM, Potter EV, Lewy PR, Jennings RB, Herdson PB (1977) Occult lupus nephropathy: a correlated light, electron and immunofluorescent microscopic study. Histopathology 1:401–419PubMed Weis LS, Pachman LM, Potter EV, Lewy PR, Jennings RB, Herdson PB (1977) Occult lupus nephropathy: a correlated light, electron and immunofluorescent microscopic study. Histopathology 1:401–419PubMed
15.
Zurück zum Zitat Mahajan SK, Ordonez NG, Feitelson PJ, Lim VS, Spargo BH, Katz AI (1977) Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 56:493–501 Mahajan SK, Ordonez NG, Feitelson PJ, Lim VS, Spargo BH, Katz AI (1977) Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 56:493–501
16.
Zurück zum Zitat Kozeny GA, Barr W, Bansal VK, Vertuno LL, Fresco R, Robinson J, Hano JE (1987) Occurrence of renal tubular dysfunction in lupus nephritis. Arch Intern Med 147:891–895CrossRefPubMed Kozeny GA, Barr W, Bansal VK, Vertuno LL, Fresco R, Robinson J, Hano JE (1987) Occurrence of renal tubular dysfunction in lupus nephritis. Arch Intern Med 147:891–895CrossRefPubMed
17.
Zurück zum Zitat Sesso R, Rettori R, Nishida S, Sato E, Ajzen H, Pereira AB (1994) Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant 9:367–371 Sesso R, Rettori R, Nishida S, Sato E, Ajzen H, Pereira AB (1994) Assessment of lupus nephritis activity using urinary retinol-binding protein. Nephrol Dial Transplant 9:367–371
18.
Zurück zum Zitat Dillon SC, Taylor GM, Shah V (1998) Diagnostic value of urinary retinol binding protein in childhood nephrotic syndrome. Pediatr Nephrol 12:643–647CrossRefPubMed Dillon SC, Taylor GM, Shah V (1998) Diagnostic value of urinary retinol binding protein in childhood nephrotic syndrome. Pediatr Nephrol 12:643–647CrossRefPubMed
19.
Zurück zum Zitat Smith GC, Winterborn MH, Taylor CM, Lawson N, Guy M (1994) Assessment of retinol-binding protein excretion in normal children. Pediatr Nephrol 8:148–150PubMed Smith GC, Winterborn MH, Taylor CM, Lawson N, Guy M (1994) Assessment of retinol-binding protein excretion in normal children. Pediatr Nephrol 8:148–150PubMed
20.
Zurück zum Zitat Piqueras AI, Shah V, Hulton SA, Barratt TM, Dillon MJ (1993) Tubular proteinuria in steroid sensitive multi-relapsing nephrotic syndrome. Clin Nephrol 40:26–30PubMed Piqueras AI, Shah V, Hulton SA, Barratt TM, Dillon MJ (1993) Tubular proteinuria in steroid sensitive multi-relapsing nephrotic syndrome. Clin Nephrol 40:26–30PubMed
21.
Zurück zum Zitat Gibb DM, Tomlinson PA, Dalton NR, Turner C, Shah V, Barratt TM (1989) Renal tubular proteinuria and microalbuminuria in diabetic patients. Arch Dis Child 64:129–134 Gibb DM, Tomlinson PA, Dalton NR, Turner C, Shah V, Barratt TM (1989) Renal tubular proteinuria and microalbuminuria in diabetic patients. Arch Dis Child 64:129–134
22.
Zurück zum Zitat Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86:447–458PubMed Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, Symmons DP, Viner N, Zoma A (1993) The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86:447–458PubMed
23.
Zurück zum Zitat Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C (1982) Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 57:611–615 Morris MC, Allanby CW, Toseland P, Haycock GB, Chantler C (1982) Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 57:611–615
24.
Zurück zum Zitat Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60:1893–1903CrossRefPubMed Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J (2001) Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 60:1893–1903CrossRefPubMed
25.
Zurück zum Zitat Hurtado A, Asato C, Escudero E, Stromquist CS, Urcia J, Hurtado ME, La Cruz S de, Wener MH, Zavala R, Johnson RJ (1999) Clinicopathologic correlations in lupus nephritis in Lima, Peru. Nephron 83:323–330CrossRefPubMed Hurtado A, Asato C, Escudero E, Stromquist CS, Urcia J, Hurtado ME, La Cruz S de, Wener MH, Zavala R, Johnson RJ (1999) Clinicopathologic correlations in lupus nephritis in Lima, Peru. Nephron 83:323–330CrossRefPubMed
26.
Zurück zum Zitat Jacobsen S, Starklint H, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, Overeem Hansen G van, Skaarup B, Hansen TM, Podenphant J, Halberg P (1999) Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28:288–299CrossRefPubMed Jacobsen S, Starklint H, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, Tarp U, Poulsen LH, Overeem Hansen G van, Skaarup B, Hansen TM, Podenphant J, Halberg P (1999) Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28:288–299CrossRefPubMed
27.
Zurück zum Zitat Singh AK, Ucci A, Madias NE (1996) Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 27:273–278PubMed Singh AK, Ucci A, Madias NE (1996) Predominant tubulointerstitial lupus nephritis. Am J Kidney Dis 27:273–278PubMed
28.
Zurück zum Zitat Yamamoto T, Nagase M, Hishida A, Honda N (1993) Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy. Lupus 2:261–268PubMed Yamamoto T, Nagase M, Hishida A, Honda N (1993) Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy. Lupus 2:261–268PubMed
29.
Zurück zum Zitat Wei CH, Ho YS, Chou BL, Sheu LF, Shieh SD, Chen A, Tu YC (1993) Lupus nephritis, emphasizing tubulointerstitial lesions: a clinico-pathological analysis. Chin Med J (Taipei) 51:27–32 Wei CH, Ho YS, Chou BL, Sheu LF, Shieh SD, Chen A, Tu YC (1993) Lupus nephritis, emphasizing tubulointerstitial lesions: a clinico-pathological analysis. Chin Med J (Taipei) 51:27–32
30.
Zurück zum Zitat Park MH, D’Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309–319PubMed Park MH, D’Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309–319PubMed
31.
Zurück zum Zitat O’Dell JR, Hays RC, Guggenheim SJ, Steigerwald JC (1985) Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med 145:1996–1999 O’Dell JR, Hays RC, Guggenheim SJ, Steigerwald JC (1985) Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med 145:1996–1999
32.
Zurück zum Zitat Guy JM, Brammah TB, Holt L, Bernstein RM, McMurray JR, Tieszen K, Cooper RG (1997) Urinary excretion of albumin and retinol binding protein in systemic lupus erythematosus. Ann Clin Biochem 34:668–674PubMed Guy JM, Brammah TB, Holt L, Bernstein RM, McMurray JR, Tieszen K, Cooper RG (1997) Urinary excretion of albumin and retinol binding protein in systemic lupus erythematosus. Ann Clin Biochem 34:668–674PubMed
33.
Zurück zum Zitat Borg EJ ter, Jong PE de, Meijer SS, Kallenberg CG (1991) Tubular dysfunction in proliferative lupus nephritis. Am J Nephrol 11:16–22PubMed Borg EJ ter, Jong PE de, Meijer SS, Kallenberg CG (1991) Tubular dysfunction in proliferative lupus nephritis. Am J Nephrol 11:16–22PubMed
34.
Zurück zum Zitat Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY (2000) Increased excretions of beta-2 microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85:207–214CrossRefPubMed Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY (2000) Increased excretions of beta-2 microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron 85:207–214CrossRefPubMed
35.
Zurück zum Zitat Cook ME, Wallin JD, Thakur VD, Kadowitz PJ, McNamara DB, Garcia MM, Lipani JA, Poland M (1997) Comparative effects of nabumetone, sulindac, and ibuprofen on renal function. J Rheumatol 24:1137–1144PubMed Cook ME, Wallin JD, Thakur VD, Kadowitz PJ, McNamara DB, Garcia MM, Lipani JA, Poland M (1997) Comparative effects of nabumetone, sulindac, and ibuprofen on renal function. J Rheumatol 24:1137–1144PubMed
36.
Zurück zum Zitat Mohrmann M, Ansorge S, Schmich U, Schonfeld B, Brandis M (1994) Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr Nephrol 8:157–163PubMed Mohrmann M, Ansorge S, Schmich U, Schonfeld B, Brandis M (1994) Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture. Pediatr Nephrol 8:157–163PubMed
37.
Zurück zum Zitat Cortes-Hernandez J, Ordi-Ros J, Labrador M, Segarra A, Tovar JL, Balada E, Vilardell-Tarres M (2003) Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus 12:287–296CrossRefPubMed Cortes-Hernandez J, Ordi-Ros J, Labrador M, Segarra A, Tovar JL, Balada E, Vilardell-Tarres M (2003) Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus 12:287–296CrossRefPubMed
38.
Zurück zum Zitat Sinniah R, Khan TN (1999) Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases. Ultrastruct Pathol 23:359–368CrossRefPubMed Sinniah R, Khan TN (1999) Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases. Ultrastruct Pathol 23:359–368CrossRefPubMed
39.
Zurück zum Zitat Alexopoulos E, Seron D, Hartley RB, Cameron JS (1990) Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37:100–109PubMed Alexopoulos E, Seron D, Hartley RB, Cameron JS (1990) Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37:100–109PubMed
40.
Zurück zum Zitat Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72:779–833PubMed Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72:779–833PubMed
41.
Zurück zum Zitat Schwartz MM, Fennell JS, Lewis EJ (1982) Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 13:534–547PubMed Schwartz MM, Fennell JS, Lewis EJ (1982) Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 13:534–547PubMed
42.
Zurück zum Zitat De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, Singh RR (2004) An ACE inhibitor reduces Th2 cytokines and TGF-beta-1 and TGF-beta-2 isoforms in murine lupus nephritis. Kidney Int 65:846–859CrossRefPubMed De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, Singh RR (2004) An ACE inhibitor reduces Th2 cytokines and TGF-beta-1 and TGF-beta-2 isoforms in murine lupus nephritis. Kidney Int 65:846–859CrossRefPubMed
Metadaten
Titel
Renal tubular dysfunction in children with systemic lupus erythematosus
verfasst von
Stephen D. Marks
Vanita Shah
Clarissa Pilkington
Patricia Woo
Michael J. Dillon
Publikationsdatum
01.02.2005
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 2/2005
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1707-6

Weitere Artikel der Ausgabe 2/2005

Pediatric Nephrology 2/2005 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.